Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
J Natl Cancer Inst 101:946-958, Armstrong,G.T.,et al, 2009
Outcome in Adult Low-Grade Glioma: The Impact of Prognostic Factors and Treatment
Neurol 69:1366-1373, Schiff,D.,et al, 2007
Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017
Maintenance Therapy with Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
JAMA 314:2535-2543,2511, Stupp, R.,et al, 2015
Bevacizumab in Glioblastoma - Still Much to Learn
NEJM 370:764-765, Fine, H.A., 2014
Malignant Gliomas in Adults
NEJM 359:492-507, Wen,P.Y. &Kesari,S., 2008
Gliomatosis Cerebri: Molecular Pathology and Clinical Course
Ann Neurol 52:390-399,389, Herrlinger,U.,et al, 2002
Long-Term Outcome of Low-Grade Oligodendroglioma and Mixed Glioma
Neurol 54:1442-1448,1402, Olson,J.D.,et al, 2000
Supratentorial Low Grade Astrocytoma:Prognostic Factors, Dedifferentiation, and the Issue of Early Versus Late Surgery
JNNP 64:581-587, van Veelen,M.L.C.,et al, 1998
Brain Tumors in the Elderly
Arch Neurol 55:922-928, Lowry,J.K.,et al, 1998
Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997
Radiotherapy for Malignant Glioma
BMJ 313:1500-1501, Gregor,A.,et al, 1996
Suspected Low-Grade Glioma:Is Deferring Treatment Safe
Ann Neurol 31:431-436, 4371992., Recht,L.D.,et al, 1992
Primary CNS Lymphomas:Natural Hx & Response to Radiation Therapy in 55 Pt with AIDS
J Neurosurg 73:206-211, Baumgartner,J.E.,et al, 1990
Neonatal Brain Tumors:CT & MR Findings
J Comput Assist Tomogr 12:10-20, Radkowski,M.A.,et al, 1988
Cerebral Reticulum Cell Sarcoma
Arch Neurol 36:727, DeCoul,A.A.W.,et al, 1979